DBS analyst Dale Lai maintained a Buy rating on ESR-REIT (CGIUF – Research Report) today and set a price target of S$0.31. The company’s shares ...

The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.

Patients with axSpA and early-stage hypertension face elevated risks for CVEs, likely due to their high inflammatory burden.

The ESR Group's latest forecast sees mortgage rates closing 2025 and 2026 at 6.5% and 6.3%, respectively, up from the previous forecast of 6.2% and 6.0%. Additionally, the ESR Group expects home ...

In a report released today, Dale Lai from DBS maintained a Buy rating on Digital Core REIT (DCRU – Research Report), with a price target of ...

The recent jump in the 10-year Treasury yield and the resulting rise in mortgage rates are expected to continue to weigh on existing home sales in the near future, likely keeping them at or near their ...

Part 4 #macross #anime #gaming ...

The organization is pushing forward with implementation of an ambitious community development agenda, with the help of community partners.

Founded in 2010 and administered by a six-strong Board of Trustees, the Meningitis Foundation Aotearoa New Zealand strives to ...

Its financial leverage is also seen to remain below 23%. Dai-ichi Life Insurance Company’s exposure to risky assets is seen ...

The coprimary endpoints were the mean change from baseline in disease activity score 28 using erythrocyte sedimentation rate (DAS28-ESR) at week 12 and week 24. Findings showed the estimated ...